|Impact of the Everolimus-Eluting Stent on Stent ThrombosisA Meta-Analysis of 13 Randomized Trials|
U Baber, R Mehran, SK Sharma, S Brar, J Yu, JW Suh, HS Kim, SJ Park, ...
Journal of the American College of Cardiology 58 (15), 1569-1577, 2011
|Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy|
A Narula, R Mehran, G Weisz, GD Dangas, J Yu, P Généreux, E Nikolsky, ...
European heart journal 35 (23), 1533-1540, 2014
|Gut flora and bacterial translocation in chronic liver disease|
J Almeida, S Galhenage, J Yu, J Kurtovic, SM Riordan
World journal of gastroenterology: WJG 12 (10), 1493, 2006
|Sex-based differences in outcomes with transcatheter aortic valve therapy: TVT registry from 2011 to 2014|
J Chandrasekhar, G Dangas, J Yu, S Vemulapalli, S Suchindran, AN Vora, ...
Journal of the American College of Cardiology 68 (25), 2733-2744, 2016
|Incidence and angiographic characteristics of patients With apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS‐AMI trial: An analysis from a …|
A Prasad, G Dangas, M Srinivasan, J Yu, BJ Gersh, R Mehran, GW Stone
Catheterization and Cardiovascular Interventions 83 (3), 343-348, 2014
|Sex‐based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS …|
J Yu, R Mehran, L Grinfeld, K Xu, E Nikolsky, BR Brodie, B Witzenbichler, ...
Catheterization and Cardiovascular Interventions 85 (3), 359-368, 2015
|High‐Intensity Interval Training for Patients With Cardiovascular Disease—Is It Safe? A Systematic Review|
MA Wewege, D Ahn, J Yu, K Liou, A Keech
Journal of the American Heart Association 7 (21), e009305, 2018
|Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial)|
AI Larsen, DWT Nilsen, J Yu, R Mehran, E Nikolsky, AJ Lansky, A Caixeta, ...
The American journal of cardiology 111 (5), 643-648, 2013
|Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing …|
E Nikolsky, R Mehran, GD Dangas, J Yu, H Parise, K Xu, SJ Pocock, ...
The American journal of cardiology 109 (6), 831-838, 2012
|Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS …|
RH Mehta, J Yu, JP Piccini, JE Tcheng, ME Farkouh, J Reiffel, M Fahy, ...
The American journal of cardiology 109 (6), 805-812, 2012
|Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial.|
P Tobbia, BR Brodie, B Witzenbichler, C Metzger, G Guagliumi, J Yu, ...
EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2013
|New insights into the risk factors of contrast-induced encephalopathy|
J Yu, G Dangas
J Endovasc Ther 18 (4), 545-6, 2011
|B-type Natriuretic Peptide and Risk of Contrast-Induced Acute Kidney Injury in Acute ST-Segment–Elevation Myocardial Infarction: A Substudy from the HORIZONS-AMI Trial|
R Jarai, G Dangas, K Huber, K Xu, BR Brodie, B Witzenbichler, ...
Circulation: Cardiovascular Interventions 5 (6), 813-820, 2012
|Safety and Efficacy of High-Versus Low-Dose Aspirin After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial InfarctionThe HORIZONS-AMI (Harmonizing …|
J Yu, R Mehran, GD Dangas, BE Claessen, U Baber, K Xu, H Parise, ...
JACC: Cardiovascular Interventions 5 (12), 1231-1238, 2012
|Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial|
T Rakowski, D Dudek, A Dziewierz, J Yu, B Witzenbichler, G Guagliumi, ...
EuroIntervention 8 (11), 1307-1314, 2013
|Sex-based differences in cessation of dual-antiplatelet therapy following percutaneous coronary intervention with stents|
J Yu, U Baber, I Mastoris, G Dangas, S Sartori, PG Steg, DJ Cohen, ...
JACC: Cardiovascular Interventions 9 (14), 1461-1469, 2016
|Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity|
U Baber, J Bander, R Karajgikar, K Yadav, A Hadi, K Theodoropolous, ...
Thrombosis and haemostasis 110 (07), 118-123, 2013
|Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty|
A Kini, J Yu, MG Cohen, R Mehran, U Baber, S Sartori, GJ Vlachojannis, ...
EuroIntervention 10 (3), 312-9, 2014
|The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: A sub‐analysis of the BRAVO study|
B O'Neill, V Singh, A Kini, R Mehran, E Jacobs, D Knopf, CE Alfonso, ...
Catheterization and Cardiovascular Interventions 83 (1), 148-153, 2014
|Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes …|
E Nikolsky, R Mehran, J Yu, B Witzenbichler, BR Brodie, R Kornowski, ...
The American journal of cardiology 111 (10), 1377-1386, 2013